Krka H1 Net Up Despite Lower Operating Profit

Novo Mesto, 24 July - Drug maker Krka posted a group net profit of EUR 106.6m for the first half of the year, up 6% over the same period last year, even as operating profit dropped 5% to EUR 125.7m. Group sales inched up 0.4% to EUR 599.4m, according to unaudited results released on Thursday.

Novo mesto Chairman of pharma company Krka Jože Colarič addressing a press conference to present half-year operating results. Photo: Rasto Božič/STA

Novo mesto
Chairman of pharma company Krka Jože Colarič addressing a press conference to present half-year operating results.
Photo: Rasto Božič/STA

Novo mesto Chairman of pharma company Krka Jože Colarič addressing a press conference to present half-year operating results. Photo: Rasto Božič/STA

Novo mesto
Chairman of pharma company Krka Jože Colarič addressing a press conference to present half-year operating results.
Photo: Rasto Božič/STA

Novo mesto The management of pharma company address a press conference to present half-year operating results. Photo: Rasto Božič/STA

Novo mesto
The management of pharma company address a press conference to present half-year operating results.
Photo: Rasto Božič/STA

Novo mesto The management of pharma company address a press conference to present half-year operating results. Photo: Rasto Božič/STA

Novo mesto
The management of pharma company address a press conference to present half-year operating results.
Photo: Rasto Božič/STA

Novo mesto The logo of pharma company Krka. Photo: Rasto Božič/STA

Novo mesto
The logo of pharma company Krka.
Photo: Rasto Božič/STA

The rest of this news item is available to subscribers.
The news item consists of 1.530 characters (without spaces) or 317 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

sm/jb/gj/gz
© STA, 2014